Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

S Crisafulli, J Sultana, A Fontana, F Salvo… - Orphanet journal of rare …, 2020 - Springer
Abstract Background Duchenne Muscular Dystrophy (DMD) is a rare disorder caused by
mutations in the dystrophin gene. A recent systematic review and meta-analysis of global …

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

S Ryder, RM Leadley, N Armstrong… - Orphanet journal of rare …, 2017 - Springer
Abstract Background Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal
neuromuscular disorder, present from birth, which occurs almost exclusively in males. We …

Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis

N Salari, B Fatahi, E Valipour, M Kazeminia… - Journal of orthopaedic …, 2022 - Springer
Background A variety of mutations in the largest human gene, dystrophin, cause a spectrum
from mild to severe dystrophin-associated muscular dystrophies. Duchenne (DMD) and …

[HTML][HTML] Myotonic dystrophy type 1

TD Bird - 2021 - europepmc.org
Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth
muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical …

Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes

K Yum, ET Wang, A Kalsotra - Current opinion in genetics & development, 2017 - Elsevier
Highlights•Distinct mechanisms for repeat expansion in mitotic and post-mitotic tissues of
DM patients.•Overview of the diagnostic methodologies for measuring repeat lengths in …

Regulation of fibrosis in muscular dystrophy

LR Smith, ER Barton - Matrix Biology, 2018 - Elsevier
The production of force and power are inherent properties of skeletal muscle, and regulated
by contractile proteins within muscle fibers. However, skeletal muscle integrity and function …

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

S Ait Benichou, D Jauvin, T de Serres-Bérard, M Pierre… - Gene Therapy, 2022 - nature.com
Myotonic dystrophy, or dystrophia myotonica type 1 (DM1), is a multi-systemic disorder and
is the most common adult form of muscular dystrophy. It affects not only muscles but also …

Drosophila Heart as a Model for Cardiac Development and Diseases

A Souidi, K Jagla - Cells, 2021 - mdpi.com
The Drosophila heart, also referred to as the dorsal vessel, pumps the insect blood, the
hemolymph. The bilateral heart primordia develop from the most dorsally located …

Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: a retrospective study using primary care data

IM Carey, E Banchoff, N Nirmalananthan, T Harris… - PLoS …, 2021 - journals.plos.org
Background In the UK, large-scale electronic primary care datasets can provide up-to-date,
accurate epidemiological information on rarer diseases, where specialist diagnoses from …

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells

S Dastidar, S Ardui, K Singh, D Majumdar… - Nucleic acids …, 2018 - academic.oup.com
CRISPR/Cas9 is an attractive platform to potentially correct dominant genetic diseases by
gene editing with unprecedented precision. In the current proof-of-principle study, we …